Dr. Greenberg is a clinical neurologist and neuromuscular specialist at Brigham and Women’s Hospital, and Professor of Neurology at Harvard Medical School. His work is focused on development of therapeutics for autoimmune disease and oncology. He is an inventor and developer of therapeutic molecules, including dazukibart and ulviprubart. Dr. Greenberg received an A.B. degree in mathematics from Princeton University, an M.D. degree from Harvard Medical School, an M.S. degree in medical informatics from MIT, and completed internship at MGH, neurology residency and neuromuscular disease fellowship at UCSF, and a bioinformatics fellowship at Boston Children’s Hospital.